RELMADA THERAPEUTICS, INC. Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)
RELMADA THERAPEUTICS, INC. (RLMD) reported Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) of 91.60% for the 9-month period ending 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsExpectedVolatilityRate · last filed 2018-05-14
- RELMADA THERAPEUTICS, INC. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2017-09-30 was 106.00%.
- RELMADA THERAPEUTICS, INC. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2016 was 75.00%.
- RELMADA THERAPEUTICS, INC. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2013 was 68.00%, a 6.85% decline from fiscal 2012.
- RELMADA THERAPEUTICS, INC. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2012 was 73.00%.
| Period end | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | 91.60% 10-Q · filed 2018-05-14 | |||
| 2017-12-31 | 99.18% 10-Q · filed 2018-02-12 | |||
| 2017-09-30 | 106.00% 10-Q · filed 2017-11-14 | |||
| 2017-06-30 | 106.00% 10-Q · filed 2018-05-14 | |||
| 2016-06-30 | 75.00% 10-K · filed 2017-09-28 | |||
| 2013-12-31 | 68.00% 10-KT · filed 2014-09-09 | |||
| 2012-12-31 | 73.00% 10-KT · filed 2014-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |